McNamara John K, Sudah Suleiman Y, Manzi Joseph E, Constantinescu David S, Nicholson Allen D, Menendez Mariano E
Department of Orthopaedic Surgery, Rutgers Robert Wood Johnson Medical School New Brunswick, NJ, USA.
Department of Orthopedic Surgery, Monmouth Medical Center Long Branch, NJ, USA.
JSES Rev Rep Tech. 2023 Mar 4;3(3):331-335. doi: 10.1016/j.xrrt.2023.01.010. eCollection 2023 Aug.
Massive irreparable rotator cuff tears (RCTs) are a commonly encountered orthopedic condition that can be difficult to treat. Several techniques have been described to manage these tears, with the implantable subacromial balloon spacer being one of the most recent. The device, which has only been approved for clinical use in the United States since 2021, functions by resisting the superior humeral head migration seen in the setting of massive RCTs and restoring normal shoulder biomechanics, as corroborated by cadaveric studies. However, results regarding clinical outcomes have been mixed to date, and further high-quality studies are needed to define the optimal use of the subacromial balloon spacer in the treatment of massive irreparable RCTs.
巨大的不可修复的肩袖撕裂（RCTs）是一种常见的骨科疾病，治疗起来可能很困难。已经描述了几种处理这些撕裂的技术，可植入的肩峰下球囊间隔器是最新的技术之一。该装置自2021年以来才在美国被批准用于临床，其作用是抵抗在巨大RCTs情况下出现的肱骨头向上移位，并恢复正常的肩部生物力学，尸体研究证实了这一点。然而，迄今为止关于临床结果的报道喜忧参半，需要进一步的高质量研究来确定肩峰下球囊间隔器在治疗巨大的不可修复的RCTs中的最佳应用。
